1 st edition – september 2007. written by haringey pc lit. developed from haringey and c&i...
TRANSCRIPT
Primary Care Guidelines for Common Mental IllnessPrimary Care Guidelines for Common Mental Illness
1st edition – September 2007. Written by Haringey PC LIT. Developed from Haringey and C&I guidelines.
Contents (click on heading to go to page):
Depression – Identification and assessment
Depression – Management
Antidepressants – drug choice guidance
Anxiety – Identification and management
Anxiety drug treatment guidance
Eating disorders
Psychosis and schizophrenia – identification, assessment and referral
Psychosis and schizophrenia – management following discharge from complex care team
Psychosis and schizophrenia – managing physical health
Assessing and managing risk to self
Assessing and managing risk to others
These primary care mental health guidelines are designed to help primary care practitioners assess and plan care for adults who are presenting with a range of mental health problems. They have been designed and written by the primary care LIT committee and Haringey LES team with input from experts in the field throughout Haringey using Haringey's previous and C&I’s existing guidelines as a foundation. They were written in line with 2007 national guidelines – check for updates from this date.
These guidelines are designed to be used directly fromyour computer, although can be printed off as a paper version. They are intended to help you make clinical decisions rather than direct your actions. When viewing on the web, when any underlined item is clicked on you will be connected to that page or relevant external web site (although HTPCT and BEHMHT cannot be responsible for the content or accuracy of any external web site).
If you have any questions or need to contact someone about these guidelines please contact one of the LES team in the first instance.
The LES team. July 2007: Dorian Cole (Clinical Specialist – 020 8442 6870) Dr Martin Lindsay (GP MH lead North East PBC – 020 8493 9100) Dr Belinda Agoe (GP MH lead central PBC – 020 8888 3227) Dr Muhammed Akunjee (GP MH lead South East PBC – 020 8881 9606) Dr Robert Mayer (GP MH lead West PBC – 020 8340 6628)
NICE
Where you see this sign, click on it to be directed to the latest NICE guidelines for that condition
Higher Risk Groups• Past history of depression• Family history of depression• Women who are pregnant and up to 6 months post- childbirth• Socially isolated• Those with ongoing difficult relationships• Concurrent physical illness• Multiple adverse events eg. loss, bereavement, childhood separation or abuse• Drug & alcohol misusers• Carers• Those in residential care
Higher Risk Groups• Past history of depression• Family history of depression• Women who are pregnant and up to 6 months post- childbirth• Socially isolated• Those with ongoing difficult relationships• Concurrent physical illness• Multiple adverse events eg. loss, bereavement, childhood separation or abuse• Drug & alcohol misusers• Carers• Those in residential care
Core Clinical Symptoms• depressed mood, and/or
• loss of interest, and/or • loss of energy & fatigue
Additional Symptoms
• poor concentration• reduced self-esteem & self-
confidence
• disturbed sleep• change in appetite or weight• feelings of guilt or worthlessness• agitation/slowing• pessimism/ hopelessness • suicidal thoughts or acts
Most of the day for at least 2 weeks
Other clinical signs• “Tired all the time”• Irritability• Loss of libido• Medically unexplained physical
symptoms• Depression associated with physical
illness• Frequent attendance• Self-neglect• Diurnal variationIf further systematic assessmentneeded, consider use of PHQ9, HADS or EPNDS
Core Clinical Symptoms• depressed mood, and/or
• loss of interest, and/or • loss of energy & fatigue
Additional Symptoms
• poor concentration• reduced self-esteem & self-
confidence
• disturbed sleep• change in appetite or weight• feelings of guilt or worthlessness• agitation/slowing• pessimism/ hopelessness • suicidal thoughts or acts
Most of the day for at least 2 weeks
Other clinical signs• “Tired all the time”• Irritability• Loss of libido• Medically unexplained physical
symptoms• Depression associated with physical
illness• Frequent attendance• Self-neglect• Diurnal variationIf further systematic assessmentneeded, consider use of PHQ9, HADS or EPNDS
Ante and Post Natal Care:• 1st contact – enquire about past/current mental health history
• If high risk or actual symptoms/diagnosis, GP to communicate with midwife, HV and hospital services
• Agree and write care plan
• See woman every month ante and post natal
• Observe specific pharmacological guidance
Ante and Post Natal Care:• 1st contact – enquire about past/current mental health history
• If high risk or actual symptoms/diagnosis, GP to communicate with midwife, HV and hospital services
• Agree and write care plan
• See woman every month ante and post natal
• Observe specific pharmacological guidance
Mild Depression:
At least 2 core symptoms plus at least 2 additional. Person has some difficulty continuing with ordinary activities but does not cease to function.
Mild Depression:
At least 2 core symptoms plus at least 2 additional. Person has some difficulty continuing with ordinary activities but does not cease to function.
Dysthymia:
Mild depression >2yrs
Dysthymia:
Mild depression >2yrs
Moderate Depression:
At least 2 core symptoms plus at least 3/4 additional. Person usually has considerable difficulty in continuing with normal social & work activity.
Moderate Depression:
At least 2 core symptoms plus at least 3/4 additional. Person usually has considerable difficulty in continuing with normal social & work activity.
Severe Depression:
All 3 typical symptoms plus at least 4 additional, some of which are severe. Person shows considerable distress & agitation (or retardation) & unlikely to be able to continue with normal activity.
Severe Depression:
All 3 typical symptoms plus at least 4 additional, some of which are severe. Person shows considerable distress & agitation (or retardation) & unlikely to be able to continue with normal activity.
Primary Care Guidelines for Common Mental IllnessPrimary Care Guidelines for Common Mental Illness
Depression - Identification & Assessment
First Questions to ask …
• Have you been bothered by feeling down, depressed or hopeless? How bad is this?
• Have you lost interest in things? Do you get less pleasure from things you used to enjoy?
• Are you more tired than usual?
If “yes” to the above, prompt further about individual symptoms (see core symptom box)
First Questions to ask …
• Have you been bothered by feeling down, depressed or hopeless? How bad is this?
• Have you lost interest in things? Do you get less pleasure from things you used to enjoy?
• Are you more tired than usual?
If “yes” to the above, prompt further about individual symptoms (see core symptom box)
Draft 1 – july 2007. Written by Haringey PC LIT. Developed from Haringey and C&I guidelinesBack to contents
Primary Care Guidelines for Common Mental IllnessPrimary Care Guidelines for Common Mental Illness
Depression - Management
Psychological Management
Consider referral for a specific talking therapy – Graduate Mental Health Workers (Health in Mind) , Primary Care PTS or other (ie Derman, Mind, NAFSAT, ACLC)
Psychological Management
Consider referral for a specific talking therapy – Graduate Mental Health Workers (Health in Mind) , Primary Care PTS or other (ie Derman, Mind, NAFSAT, ACLC)
Psychological ManagementRefer to START for consideration for talking therapy such as CBT, IPT, CAT
Psychological ManagementRefer to START for consideration for talking therapy such as CBT, IPT, CAT
Pharmacological Management
Currently no evidence to suggest that antidepressant medication is effective in mild depression. Prescribe only if clinically indicated.
Pharmacological Management
Currently no evidence to suggest that antidepressant medication is effective in mild depression. Prescribe only if clinically indicated.
Pharmacological Management
Consider prescribing antidepressants – first line choice Fluoxetine or Citalopram. Second line choice = venlaflaxine
Pharmacological Management
Consider prescribing antidepressants – first line choice Fluoxetine or Citalopram. Second line choice = venlaflaxine
Pharmacological Management
Prescribed antidepressants- first line choice= Fluoxetine or Citalopram. Second line choice = venlaflaxine
Pharmacological Management
Prescribed antidepressants- first line choice= Fluoxetine or Citalopram. Second line choice = venlaflaxine
BEHMHT will consider crisis and/or inpatient needs
BEHMHT will consider crisis and/or inpatient needs
under 18 – CAMHS on 020 8442 6467
18 to 65 yrs – call START on 020 8442 6714
Over 65 – call 020 8442 6702
under 18 – CAMHS on 020 8442 6467
18 to 65 yrs – call START on 020 8442 6714
Over 65 – call 020 8442 6702
Clin
ical
judg
emen
t
Primary Care and psychological Management
• Listen & Support • Inform & Educate •Patient leaflet • Problem-Solve • Increase Activity & Exercise • Increase social support • Consider other family members
•Book prescription Guided Self-help, Computerised CBT and other brief talking therapy useful – consider referral to Graduate Mental Health Workers (Health in Mind) . Also consider social care input – Harts, 60+
Primary Care and psychological Management
• Listen & Support • Inform & Educate •Patient leaflet • Problem-Solve • Increase Activity & Exercise • Increase social support • Consider other family members
•Book prescription Guided Self-help, Computerised CBT and other brief talking therapy useful – consider referral to Graduate Mental Health Workers (Health in Mind) . Also consider social care input – Harts, 60+
Primary Care Management • Listen & Support • Inform & Educate • Problem-Solve • Self-help and book prescription • Increase Activity & Exercise •
• Increase social support • Consider other family members •Also consider social care input – Harts, 60+
Primary Care Management • Listen & Support • Inform & Educate • Problem-Solve • Self-help and book prescription • Increase Activity & Exercise •
• Increase social support • Consider other family members •Also consider social care input – Harts, 60+
Primary Care Management • Assess, Identify risks/stressors and protectors – see guidelines on assessing risk. Consider other family members for
support and issues of risk (ie impact on children). Negotiate and write a clear plan of care. Give information to patient and carer of out of hour support.
Primary Care Management • Assess, Identify risks/stressors and protectors – see guidelines on assessing risk. Consider other family members for
support and issues of risk (ie impact on children). Negotiate and write a clear plan of care. Give information to patient and carer of out of hour support.
Patie
nt c
hoic
e
ASSESS RISKASSESS RISK
Mild DepressionMild Depression
Severe DepressionSevere Depression
DysthymiaDysthymia
Moderate DepressionModerate Depression
Actively suicidal & urgent risk to self or others
Actively suicidal & urgent risk to self or others
POOR RESPONSE to adequate treatments/ complex management issues
POOR RESPONSE to adequate treatments/ complex management issues
Draft 1 – july 2007. Written by Haringey PC LIT. Developed from Haringey and C&I guidelinesBack to contents
Primary Care Guidelines for Common Mental IllnessPrimary Care Guidelines for Common Mental Illness
Antidepressants - Drug Choice Guidance
Adapted from Bazire, S. Psychotropic Drug Directory, 2005 Prices from Drug Tariff July 2007
• When an antidepressant is to be prescribed in routine care it should be an SSRI (as effective and less severe side effects than tricyclics)
• Prescriptions when possible should be generic. PCT recommend 1st line – Fluoxetine or Citalopram.
• If SSRI is not effective, different type of medication should then be offered. PCT recommend 2nd line - Venlafaxine
• Patients seem to have better outcomes if given GOOD, CLEAR INFORMATION about anti-depressants – explain drugs plus give a Patient Information Leaflet
• When an antidepressant is to be prescribed in routine care it should be an SSRI (as effective and less severe side effects than tricyclics)
• Prescriptions when possible should be generic. PCT recommend 1st line – Fluoxetine or Citalopram.
• If SSRI is not effective, different type of medication should then be offered. PCT recommend 2nd line - Venlafaxine
• Patients seem to have better outcomes if given GOOD, CLEAR INFORMATION about anti-depressants – explain drugs plus give a Patient Information Leaflet
Key Facts Key Facts
Drug Oral Start Dosemg/d
Toxicity in overdose
CV efects Sedation Anticholinergic effects
Nausea Weight gain Cost (28 days)
SSRI'sFluoxetine 20mg 0 0 0 0 ++ £2Citalopram 20mg 0 0 0 0 ++ £3Paroxetine 20mg 0 0 0 0 ++ £6Sertraline 50mg 0 0 0 0 ++ £3Tricyclics (TCA)Amitriptyline 125mg +++ +++ +++ +++ ++ £5Clomipramine 125mg + ++ ++ +++ ++ £13Dothiepin 125mg +++ ++ +++ ++ 0 £4Imipramine 125mg +++ ++ + ++ ++ £9Lofepramine 140mg 0 0 + ++ + £31OthersVenlafaxine 75mg ? ++ + 0 ++ Wt. Loss £24Mirtazapine 30mg 0 0 ++ 0 0 Wt. Gain £11Reboxetine 8mg 0 + 0 + + £19Trazodone 150-300mg + + ++ + +++ £19 to £39
Weight gain well documented
Tendency for initial weight loss then regain
No reports of weight changes
Draft 1 – july 2007. Written by Haringey PC LIT. Developed from Haringey and C&I guidelinesBack to contents
• Is the patient at risk of suicide? YES – SSRI’s (Fluoxetine or Citalopram). consider issues of toxicity in overdose• Is sedation needed? YES – Mirtazapine or ‘Older’ tricyclics • Will anticholinergic effects be particularly problematic ? YES – SSRI’s, Venlafaxine• Does the patient have significant other illness? YES – avoid tricyclics, check BNF for individual drugs eg. CV/hepatic/renal imparirment• Is the patient taking OTC or prescribed medications? YES – check BNF for significant interactions• Does the patient have symptoms of anxiety? YES - see anxiety guidelines• Is the patient pregnant or breastfeeding? YES – avoid drugs in 1st trimester if possible. Only use if benefits of treatment outweigh possible risks to foetus/baby & of
not treating the mother. Discuss with psychiatrist or psychiatric pharmacist. For complex cases: National Centre for Drugs in Pregnancy 0191 232 1525
• Is the patient at risk of suicide? YES – SSRI’s (Fluoxetine or Citalopram). consider issues of toxicity in overdose• Is sedation needed? YES – Mirtazapine or ‘Older’ tricyclics • Will anticholinergic effects be particularly problematic ? YES – SSRI’s, Venlafaxine• Does the patient have significant other illness? YES – avoid tricyclics, check BNF for individual drugs eg. CV/hepatic/renal imparirment• Is the patient taking OTC or prescribed medications? YES – check BNF for significant interactions• Does the patient have symptoms of anxiety? YES - see anxiety guidelines• Is the patient pregnant or breastfeeding? YES – avoid drugs in 1st trimester if possible. Only use if benefits of treatment outweigh possible risks to foetus/baby & of
not treating the mother. Discuss with psychiatrist or psychiatric pharmacist. For complex cases: National Centre for Drugs in Pregnancy 0191 232 1525
Questions to consider when choosing antidepressantsQuestions to consider when choosing antidepressants
Primary Care Guidelines for Common Mental IllnessPrimary Care Guidelines for Common Mental Illness
Antidepressants - Drug Treatment Guidance
RESPONSE
No response or poorly tolerated
(CHECK COMPLIANCE FIRST)
Poorly tolerated
NO RESPONSE
(CHECK COMPLIANCE FIRST)
RESPONSE
RESPONSE• Give selected antidepressant
• Titrate to therapeutic dose
• Assess response over 4-6wks (longer in elderly)
• Increase dose after 2 & 4 weeks if appropriate
• Give selected antidepressant
• Titrate to therapeutic dose
• Assess response over 4-6wks (longer in elderly)
• Increase dose after 2 & 4 weeks if appropriate
• Give an antidepressant from a different class
• Titrate to therapeutic dose
• Assess response over 4-6wks (longer in elderly)
• Increase dose after 2 & 4 weeks if appropriate
• Give an antidepressant from a different class
• Titrate to therapeutic dose
• Assess response over 4-6wks (longer in elderly)
• Increase dose after 2 & 4 weeks if appropriate
Continue for 4-6 months at same dosage once well (12mths in the elderly)
Continue for 4-6 months at same dosage once well (12mths in the elderly)
For patients with 3+ episodes in the last 5yrs, or a total of 5+ episodes, consider maintenance treatment for 5 years
For patients with 3+ episodes in the last 5yrs, or a total of 5+ episodes, consider maintenance treatment for 5 years
• Give an antidepressant from a different class (or from within class – see BNF for washout periods)
• Titrate to therapeutic dose
• Assess response over 4-6wks (longer in elderly)
• Increase dose after 2 & 4 weeks if appropriate
• Give an antidepressant from a different class (or from within class – see BNF for washout periods)
• Titrate to therapeutic dose
• Assess response over 4-6wks (longer in elderly)
• Increase dose after 2 & 4 weeks if appropriate
To stop treatment, taper dose and/or frequency over a min. of 4wks
To stop treatment, taper dose and/or frequency over a min. of 4wks
Taper dose over 6mths for those on longer-term maintenance treatment
Taper dose over 6mths for those on longer-term maintenance treatment
Advise the patient:
• That it may take 2-4wks to start noticing the positive effects (4-8wks in older people)
• Of the common side effects they are likely to experience
• That they need to keep taking the medication even when they feel better
• That antidepressants are NOT addictive – but must not stop suddenly
• Of dosing& titration regime where appropriate• To come back and see you in 1-4wkswhether or not
they have been taking medication
• That they should consult you before stopping taking the medication
Advise the patient:
• That it may take 2-4wks to start noticing the positive effects (4-8wks in older people)
• Of the common side effects they are likely to experience
• That they need to keep taking the medication even when they feel better
• That antidepressants are NOT addictive – but must not stop suddenly
• Of dosing& titration regime where appropriate• To come back and see you in 1-4wkswhether or not
they have been taking medication
• That they should consult you before stopping taking the medication
Drug CounsellingDrug Counselling
• Choose drug in line with drug choice guidelines
overleaf• Aim for the minimum effective dose • Agree follow-up plan – Review every 1-2 weeks at
start of treatment. Monitoring of suicide risk essential if high risk. If low risk, every two to four weeks
• Provide good, clear drug counselling plus a patient information leaflet
• Choose drug in line with drug choice guidelines
overleaf• Aim for the minimum effective dose • Agree follow-up plan – Review every 1-2 weeks at
start of treatment. Monitoring of suicide risk essential if high risk. If low risk, every two to four weeks
• Provide good, clear drug counselling plus a patient information leaflet
Initiating medicationInitiating medication Treatment RegimeTreatment Regime
Draft 1 – july 2007. Written by Haringey PC LIT. Developed from Haringey and C&I guidelinesBack to contents
No response or poorly tolerated
(CHECK COMPLIANCE FIRST)
RESPONSE
No response or poorly tolerated
(CHECK COMPLIANCE FIRST)
Link to United Kingdom psychiatric pharmacy group web site
Core Symptoms
• Mental symptoms: eg. feeling ‘on edge’, apprehension, worry about future, fear of something bad happening, difficulty concentrating, depressive symptoms
• Physical tension & arousal: eg. restlessness, muscle tension, inability to relax, sweating, stomach or chest pains, dizziness, overbreathing NB. May present as physical complaint
• Behaviour change: eg. avoidance of feared situations
Core Symptoms
• Mental symptoms: eg. feeling ‘on edge’, apprehension, worry about future, fear of something bad happening, difficulty concentrating, depressive symptoms
• Physical tension & arousal: eg. restlessness, muscle tension, inability to relax, sweating, stomach or chest pains, dizziness, overbreathing NB. May present as physical complaint
• Behaviour change: eg. avoidance of feared situations
Predisposing factors• Life events/ stressors• Anxious personality
Predisposing factors• Life events/ stressors• Anxious personality
Assessment• Screening questions:“How are you feeling in yourself?”“Have you found yourself worrying a lot?”• Consider other causes of symptoms e.g.
thyrotoxicosis, stimulant drug use• Consider comorbidity inc depression• Look out for drug/alcohol use• Consider somatic problems, eg pain• Determine:
- duration of symptoms- severity of impairment- degree of avoidance- degree of accompanying depression
• Assess risk
Assessment• Screening questions:“How are you feeling in yourself?”“Have you found yourself worrying a lot?”• Consider other causes of symptoms e.g.
thyrotoxicosis, stimulant drug use• Consider comorbidity inc depression• Look out for drug/alcohol use• Consider somatic problems, eg pain• Determine:
- duration of symptoms- severity of impairment- degree of avoidance- degree of accompanying depression
• Assess risk
Primary care management• Educate about anxiety• Provide self-help information & support• Book prescription• Encourage relaxation techniques, regular
exercise and sleep & stress management• Avoid over-investigation of physical
symptoms and help patient make links between anxiety & presenting physical symptoms
• Manage comorbidity & substance use• Watchful waiting
Primary care management• Educate about anxiety• Provide self-help information & support• Book prescription• Encourage relaxation techniques, regular
exercise and sleep & stress management• Avoid over-investigation of physical
symptoms and help patient make links between anxiety & presenting physical symptoms
• Manage comorbidity & substance use• Watchful waiting
Primary care psychological management
• Consider referral for talking therapies, in particular guided self help (Health in Mind)
• CBT, as second line treatment if symptoms are causing significant distress or impairment of functioning
Primary care psychological management
• Consider referral for talking therapies, in particular guided self help (Health in Mind)
• CBT, as second line treatment if symptoms are causing significant distress or impairment of functioning
Pharmacological management
• Medication should be a third line treatment in the management of anxiety
• Drugs may be indicated if:- significant depressive symptoms (esp. in Mixed Anxiety Depression)- persistent or very disabling anxiety symptoms-Short term only
Pharmacological management
• Medication should be a third line treatment in the management of anxiety
• Drugs may be indicated if:- significant depressive symptoms (esp. in Mixed Anxiety Depression)- persistent or very disabling anxiety symptoms-Short term only
Primary Care Guidelines for Common Mental IllnessPrimary Care Guidelines for Common Mental Illness
Anxiety - Identification & Management
Discuss with START (020 8442 6714) if:• Chronic, severe, disabling symptoms• Poor response to other treatments• Risk of suicide or self-harm
Discuss with START (020 8442 6714) if:• Chronic, severe, disabling symptoms• Poor response to other treatments• Risk of suicide or self-harm
Mixed Anxiety & Depression (MAD)• Low or sad mood & loss of interest or pleasure• Prominent anxiety or worry• Multiple depressive or anxiety symptoms
Mixed Anxiety & Depression (MAD)• Low or sad mood & loss of interest or pleasure• Prominent anxiety or worry• Multiple depressive or anxiety symptoms
Generalised Anxiety Disorder (GAD)• Excessive anxiety & worry about several events or activities• Trouble controlling these feelings• Symptoms present at least half the days in last 6 mths
Generalised Anxiety Disorder (GAD)• Excessive anxiety & worry about several events or activities• Trouble controlling these feelings• Symptoms present at least half the days in last 6 mths
Panic Disorder• Recurrent panic attacks• Worry about the cause or consequences• Attempt to avoid situations that trigger attacks • May be associated with agoraphobia
Panic Disorder• Recurrent panic attacks• Worry about the cause or consequences• Attempt to avoid situations that trigger attacks • May be associated with agoraphobia
Phobic Disorders• Agoraphobia• Social phobia• Specific phobia
Obsessive-compulsive (OCD)• Recurrent thoughts or impulses• Attempts to suppress or “neutralise” these• Repetitive physical or mental behaviours
Post Traumatic Stress Disorder (PTSD)• Lasting response (at least 2 weeks) to a traumatic event that impairs functioning• Intrusive memories: flashbacks/ nightmares• Avoidance behaviour• Numbness, detachment• hyperarousal, anxiety, irritability• Treatment only indicated following several months of symptoms
Phobic Disorders• Agoraphobia• Social phobia• Specific phobia
Obsessive-compulsive (OCD)• Recurrent thoughts or impulses• Attempts to suppress or “neutralise” these• Repetitive physical or mental behaviours
Post Traumatic Stress Disorder (PTSD)• Lasting response (at least 2 weeks) to a traumatic event that impairs functioning• Intrusive memories: flashbacks/ nightmares• Avoidance behaviour• Numbness, detachment• hyperarousal, anxiety, irritability• Treatment only indicated following several months of symptoms
Common Anxiety Disorders in Primary Care (co-existence should be considered)
Common Anxiety Disorders in Primary Care (co-existence should be considered)
Other Anxiety Disorders Other Anxiety Disorders
Draft 1 – july 2007. Written by Haringey PC LIT. Developed from Haringey and C&I guidelinesBack to contents
Mild
Moderate
Severe
Primary Care Guidelines for Common Mental IllnessPrimary Care Guidelines for Common Mental Illness
Anxiety - Drug Treatment GuidanceNB. Self-management strategies & talking therapies should be the first line treatments for anxiety disorders. Medication may be considered for acute distress, for persistent or disabling anxiety symptoms, or where there are significant depressive symptoms
NB. Self-management strategies & talking therapies should be the first line treatments for anxiety disorders. Medication may be considered for acute distress, for persistent or disabling anxiety symptoms, or where there are significant depressive symptoms
Anxiety DisorderAnxiety Disorder Licensed DrugLicensed Drug
Mixed Anxiety & Depression (MAD)Mixed Anxiety & Depression (MAD)
Generalised Anxiety Disorder (GAD)Generalised Anxiety Disorder (GAD)
Obsessive-Compulsive Disorder (OCD)Obsessive-Compulsive Disorder (OCD)
Social Phobia (Generalised)Social Phobia (Generalised)
Post-Traumatic Stress Disorder (PTSD)Post-Traumatic Stress Disorder (PTSD)
Panic Disorder (and agoraphobia)Panic Disorder (and agoraphobia)
Specific PhobiasSpecific Phobias
Social Phobia (Non-Generalised)Social Phobia (Non-Generalised)
Acute Stress DisorderAcute Stress Disorder
No specific drug licensed. Follow antidepressant prescribing guidelines. Consider drug anxiolytic properties.
No specific drug licensed. Follow antidepressant prescribing guidelines. Consider drug anxiolytic properties.
• 1 - Paroxetine• 2 - Venlafaxine• 3 - Buspirone
• 1 - Paroxetine• 2 - Venlafaxine• 3 - Buspirone
• Paroxetine• Paroxetine
• 1 - Citalopram• 2 - Paroxetine
• 1 - Citalopram• 2 - Paroxetine
• 1 - Fluoxetine• 2 - Paroxetine• 3 - Sertraline• 4 - Clomipramine
• 1 - Fluoxetine• 2 - Paroxetine• 3 - Sertraline• 4 - Clomipramine
Only consider pharmacotherapy for symptomatic management in one-off/ short-term circumstances e.g. beta-blockers/ benzodiazapines for air travel
Only consider pharmacotherapy for symptomatic management in one-off/ short-term circumstances e.g. beta-blockers/ benzodiazapines for air travel
• When using antidepressant medication to treat anxiety disorders, start therapy at ¼-½ of normal recommended dose for depression to minimise risk of exacerbating the anxiety (“activation syndrome”) and increase compliance. Use syrup if necessary.
Key message: “Start Low, Go Slow”
• Titrate to therapeutic dose If symptoms show improvement after 12wks of treatment, continue for a minimum of one year. Withdraw drug slowly.
• When using antidepressant medication to treat anxiety disorders, start therapy at ¼-½ of normal recommended dose for depression to minimise risk of exacerbating the anxiety (“activation syndrome”) and increase compliance. Use syrup if necessary.
Key message: “Start Low, Go Slow”
• Titrate to therapeutic dose If symptoms show improvement after 12wks of treatment, continue for a minimum of one year. Withdraw drug slowly.
• Benzodiazepines ( avoid short acting such as Lorazapam) • Up to 7 days. With caution.
• Benzodiazepines ( avoid short acting such as Lorazapam) • Up to 7 days. With caution.
Treatment RegimeTreatment Regime
Draft 1 – july 2007. Written by Haringey PC LIT. Developed from Haringey and C&I guidelinesBack to contents
Preferred options
as advised by the
Haringey TPCT pharmacy team
Core Clinical SymptomsANOREXIA NERVOSA • Body weight maintained 15% below expected for
age and height/ BMI < 17.5kg/m2
• Weight loss self-induced by
•Restricting intake
•Self induced vomiting and/or purging
•Excessive exercise
•Use of drugs
• Morbid dread of fatness
• Self set low weight threshold
• Disturbance of endocrine system
• Anorexia Nervosa has the highest death rate of any psychological disorder
BULIMIA NERVOSA
• Bingeing, with preoccupation with food and craving
• Attempts to counteract excess calorie intake by
•Self induced vomiting
•Self induced purging
•Alternating periods of starvation and bingeing
•Use of drugs and/or neglect of insulin use in diabetes
• Morbid dread of fatness
• Self set low weight threshold
• Possible history of anorexia
Core Clinical SymptomsANOREXIA NERVOSA • Body weight maintained 15% below expected for
age and height/ BMI < 17.5kg/m2
• Weight loss self-induced by
•Restricting intake
•Self induced vomiting and/or purging
•Excessive exercise
•Use of drugs
• Morbid dread of fatness
• Self set low weight threshold
• Disturbance of endocrine system
• Anorexia Nervosa has the highest death rate of any psychological disorder
BULIMIA NERVOSA
• Bingeing, with preoccupation with food and craving
• Attempts to counteract excess calorie intake by
•Self induced vomiting
•Self induced purging
•Alternating periods of starvation and bingeing
•Use of drugs and/or neglect of insulin use in diabetes
• Morbid dread of fatness
• Self set low weight threshold
• Possible history of anorexia
Mild Anorexia:
BMI >17kg/m2
No additional co morbidity
Mild Anorexia:
BMI >17kg/m2
No additional co morbidity
Moderate Anorexia:
•BMI 15 – 17kg/m2
•No evidence of system failure
Moderate Anorexia:
•BMI 15 – 17kg/m2
•No evidence of system failure
Severe Bulimia
Daily purging
Electrolyte imbalance
Co-morbidity
Severe Bulimia
Daily purging
Electrolyte imbalance
Co-morbidity
Severe Anorexia
BMI <15kg/m2
Rapid weight loss
Evidence of system failure
Severe Anorexia
BMI <15kg/m2
Rapid weight loss
Evidence of system failure
Primary Care Guidelines for Common Mental IllnessPrimary Care Guidelines for Common Mental Illness
Eating Disorders- Identification & Management
Assessment
• Height and Weight, BMI (weight kg /height m squared)
Consider
• Other causes of weight loss, inc thyroid disease, stimulant use
• Investigations Full blood count, blood chemistry, pulse, blood pressure
• Other difficulties associated with binging and purging ie Tooth decay
• Symptoms of depression (difficult to treat until nutritional state is successfully being treated)
Assessment
• Height and Weight, BMI (weight kg /height m squared)
Consider
• Other causes of weight loss, inc thyroid disease, stimulant use
• Investigations Full blood count, blood chemistry, pulse, blood pressure
• Other difficulties associated with binging and purging ie Tooth decay
• Symptoms of depression (difficult to treat until nutritional state is successfully being treated)
Draft 1 – july 2007. Written by Haringey PC LIT. Developed from Haringey and C&I guidelinesBack to contents
Monitor for 8 weeks
Give information
Book prescription
Use of self help books
Food diary
Explore extent of problem
Consider involvement of family
Consider referral if failure to respond
Monitor for 8 weeks
Give information
Book prescription
Use of self help books
Food diary
Explore extent of problem
Consider involvement of family
Consider referral if failure to respond
Mild and moderate Bulimia
Mild and moderate Bulimia
Urgent referral and admission to
acute medical hospital if life-
threatening
Urgent referral and admission to
acute medical hospital if life-
threatening
under 18 – CAMHS on 020 8442 6467
18 to 65 yrs – call START on 020 8442 6714
under 18 – CAMHS on 020 8442 6467
18 to 65 yrs – call START on 020 8442 6714
The Phoenix Wing, St Ann's
Hospital, St Ann's Road,
London N15 3TH
Telephone Number: 020 8442 6387Fax Number: 020 8442 6192
The Phoenix Wing, St Ann's
Hospital, St Ann's Road,
London N15 3TH
Telephone Number: 020 8442 6387Fax Number: 020 8442 6192
Primary Care Guidelines for Common Mental IllnessPrimary Care Guidelines for Common Mental Illness
Psychosis and Schizophrenia – Assessment & referral
Higher Risk Groups• Family history of psychoses• Past history of psychoses• Drug misusers• Onset most commonly in 2nd or 3rd decade –
but can occur at any age
Higher Risk Groups• Family history of psychoses• Past history of psychoses• Drug misusers• Onset most commonly in 2nd or 3rd decade –
but can occur at any age
Urgent /Emergency Referral to START 020 8442 6714Urgent /Emergency Referral to START 020 8442 6714
In all cases consider starting antipsychotic medication Risperidone is first line treatment
In all cases consider starting antipsychotic medication Risperidone is first line treatment
Discussion with Link worker/psychiatrist – refer to START with patient’s agreement.
Consider referral to START depending on:• Patients views• Previous history • Problems with medication• Concerns about comorbid substance misuse• Level of risk
Discussion with Link worker/psychiatrist – refer to START with patient’s agreement.
Consider referral to START depending on:• Patients views• Previous history • Problems with medication• Concerns about comorbid substance misuse• Level of risk
Referral to START 020 8442 6714
(NB: START will refer patients to Early Intervention Service when established)
Referral to START 020 8442 6714
(NB: START will refer patients to Early Intervention Service when established)
Hypomania: Over the past year, have there been times when you felt very happy indeed without a break for days on end? If yes - Was there an obvious reason for this? Did your relatives or friends think it was strange or complain about it? Thought insertion: Over the past year, have you ever felt that your thoughts were directly interfered with or controlled by some outside force or person? If yes - Did this come about in a way that many people would find hard to believe, for instance, through telepathy? Paranoia: Over the past year, have there been times when you felt that people were against you?If yes - Have there been times when you felt that people were deliberately acting to harm you or your interests?· Have there been times when you felt that a group of people were plotting to cause you serious harm or injury? Strange experiences: Over the past year, have there been times when you felt that something strange was going on? If yes - Did you feel it was so strange that other people would find it very hard to believe?Hallucinations: Over the past year, have there been times when you heard or saw things that other people couldn't? If yes- Did you at any time hear voices saying quite a few words or sentences when there was no-one around that might account for it?
Hypomania: Over the past year, have there been times when you felt very happy indeed without a break for days on end? If yes - Was there an obvious reason for this? Did your relatives or friends think it was strange or complain about it? Thought insertion: Over the past year, have you ever felt that your thoughts were directly interfered with or controlled by some outside force or person? If yes - Did this come about in a way that many people would find hard to believe, for instance, through telepathy? Paranoia: Over the past year, have there been times when you felt that people were against you?If yes - Have there been times when you felt that people were deliberately acting to harm you or your interests?· Have there been times when you felt that a group of people were plotting to cause you serious harm or injury? Strange experiences: Over the past year, have there been times when you felt that something strange was going on? If yes - Did you feel it was so strange that other people would find it very hard to believe?Hallucinations: Over the past year, have there been times when you heard or saw things that other people couldn't? If yes- Did you at any time hear voices saying quite a few words or sentences when there was no-one around that might account for it?
Prodromal Period• Early signs of deterioration in
personal functioning• Changes in affect, cognition,
thought content, motivation and behaviour
• 50% do not develop frank psychosis
• active follow up in primary care
Prodromal Period• Early signs of deterioration in
personal functioning• Changes in affect, cognition,
thought content, motivation and behaviour
• 50% do not develop frank psychosis
• active follow up in primary care
New diagnosis of psychosis – first presentation
New diagnosis of psychosis – first presentation
Patient new to the area - with previously diagnosed psychosis
Patient new to the area - with previously diagnosed psychosis
Known patient (sole management in Primary Care)
Known patient (sole management in Primary Care)
Assessment (PSQ Bebbington and Nayani, 1995)Assessment (PSQ Bebbington and Nayani, 1995)
Ante and Post Natal Care:• 1st contact – enquire about past/current MI history• If high risk or actual symptoms/diagnosis, GP to communicate with midwife, HV and hospital services• Refer to START - agree and write care plan Also consider social care input – Harts,• See woman every month ante and post natal
Ante and Post Natal Care:• 1st contact – enquire about past/current MI history• If high risk or actual symptoms/diagnosis, GP to communicate with midwife, HV and hospital services• Refer to START - agree and write care plan Also consider social care input – Harts,• See woman every month ante and post natal
Discussion with Link worker/psychiatrist• Manage in primary Care with SMI care plan• Anti psychotic prescribing, with pt leaflet • Monitor repeat prescribing• Consider wider social and support issues• Refer to exercise and work/education
opportunities
Discussion with Link worker/psychiatrist• Manage in primary Care with SMI care plan• Anti psychotic prescribing, with pt leaflet • Monitor repeat prescribing• Consider wider social and support issues• Refer to exercise and work/education
opportunities
Significant impact on dependant children?
Significant impact on dependant children?
Urgent referral to Children Services on
020 8489 5402
Urgent referral to Children Services on
020 8489 5402
Acutely disturbedAcutely disturbed
Draft 1 – july 2007. Written by Haringey PC LIT. Developed from Haringey and C&I guidelinesBack to contents
Primary Care Guidelines for Common Mental IllnessPrimary Care Guidelines for Common Mental Illness
Psychosis and Schizophrenia – Management following discharge from CMHT (inc Support and Recovery Teams)
If acute relapse – instigate crisis and contingency plan
Discussion with Link worker or psychiatrist –
refer to START with patient’s knowledge.• Patients views• Previous history • Problems with medication• Concerns about comorbid substance
misuse• Level of risk
If acute relapse – instigate crisis and contingency plan
Discussion with Link worker or psychiatrist –
refer to START with patient’s knowledge.• Patients views• Previous history • Problems with medication• Concerns about comorbid substance
misuse• Level of risk
Depot medicationAgree planCompetent practice nurseAppointments opportunity to assess
Depot medicationAgree planCompetent practice nurseAppointments opportunity to assess
Concordance and repeat prescriptionsMonitor repeat prescription picked upCheck for side effectsUse pt leaflet
Concordance and repeat prescriptionsMonitor repeat prescription picked upCheck for side effectsUse pt leaflet
Crisis and Contingency Plan in place (CPA)
Crisis and Contingency Plan in place (CPA)
Discharge Planning and Care PlanPt identifiedPlan agreedDates agreed
Discharge Planning and Care PlanPt identifiedPlan agreedDates agreed
Shared CareIn agreement with psychiatrist, explicitly agrees who is doing what, when, how, why and with whom.
Shared CareIn agreement with psychiatrist, explicitly agrees who is doing what, when, how, why and with whom.
Physical HealthProactive plan – utilise health action planAssess and review at least once a yearTarget smoking, eating and exercise behaviour
Physical HealthProactive plan – utilise health action planAssess and review at least once a yearTarget smoking, eating and exercise behaviour
SMI RegisterOn listCare plan in placeReviewed at least once a year
SMI RegisterOn listCare plan in placeReviewed at least once a year
Draft 1 – july 2007. Written by Haringey PC LIT. Developed from Haringey and C&I guidelines
Patients needs stableSpecialist input no longer required
Patients needs stableSpecialist input no longer required
Sole Primary Care Management
Sole Primary Care Management
Relapse IndicatorsWhy, When, Who, HowTo refer back to START
Relapse IndicatorsWhy, When, Who, HowTo refer back to START
CarersCares assessment and needsSupport and counselling for carers (Health in Mind)Regular review of carers needs
Is there a child carer? – assess needs and refer to children services
CarersCares assessment and needsSupport and counselling for carers (Health in Mind)Regular review of carers needs
Is there a child carer? – assess needs and refer to children services
Work with patient to helpimprove general well-being andfeelings of worthAccess to employment and education –
‘Tomorrow's People, Richmond Fellowship, New deal, Job centre Plus.
Consider referral/signposting to therapeutic network, and or day services
Book prescription for stress and esteem issuesStress management and relaxation skillsStructure and activity planning and
Problem solvingDebt managementAlso consider social care input – Harts, 60+
and Services for All
Work with patient to helpimprove general well-being andfeelings of worthAccess to employment and education –
‘Tomorrow's People, Richmond Fellowship, New deal, Job centre Plus.
Consider referral/signposting to therapeutic network, and or day services
Book prescription for stress and esteem issuesStress management and relaxation skillsStructure and activity planning and
Problem solvingDebt managementAlso consider social care input – Harts, 60+
and Services for All
Back to contents
Primary Care Guidelines for Common Mental IllnessPrimary Care Guidelines for Common Mental Illness
Psychosis and Schizophrenia - Physical Health Care
Focus on
Provide routine physical health checks at least 1x every year. Record on SMI register
Provide routine physical health checks at least 1x every year. Record on SMI register
Monitor increased risk of cardiovascular disease
Monitor increased risk of cardiovascular disease
Promote healthy lifestylePromote healthy lifestyle
Monitor drug side effectsMonitor drug side effects
NeurologicalNeurological
Consider:• Extrapyramidal side effects• Tardive dyskinesia
Consider:• Extrapyramidal side effects• Tardive dyskinesia
Regular monitoringRegular monitoring
To be provided usually in primary careTo be provided usually in primary care If no contact with primary careIf no contact with primary care Secondary care should monitor physical healthSecondary care should monitor physical health
Consider:• Primary prevention (use standard scoring systems)• Secondary prevention in those with established heart disease• Specific monitoring in relation to certain antipsychotic drugs (see BNF)
Consider:• Primary prevention (use standard scoring systems)• Secondary prevention in those with established heart disease• Specific monitoring in relation to certain antipsychotic drugs (see BNF)
For example, good diet and exerciseActively encourage smoking cessation
For example, good diet and exerciseActively encourage smoking cessation
EPS/akathisia LethargyWeight gain/diabetes Effects on eyesSexual dysfunction
EPS/akathisia LethargyWeight gain/diabetes Effects on eyesSexual dysfunction
Metabolic and endocrineMetabolic and endocrine WeightWeight Other side effects of medicationOther side effects of medication
Consider:• Routine urine/blood screen for diabetes• Selective screen for other endocrine
disorders (high prolactin), eg amenorroea, glalactorrhoea
Consider:• Routine urine/blood screen for diabetes• Selective screen for other endocrine
disorders (high prolactin), eg amenorroea, glalactorrhoea
Consider routine weight monitoringConsider routine weight monitoring Photosensitivity and chlorpromazinePhotosensitivity and chlorpromazine
Cover key areas on regular basis; agree frequency with service user and document in notesCover key areas on regular basis; agree frequency with service user and document in notes
Primary and secondary care services identify/allocate and document responsibilities for monitoring physical healthPrimary and secondary care services identify/allocate and document responsibilities for monitoring physical health
Promote wider well being activity: Goal setting, problem solving, access to education and employment.Stress management – referral to Therapeutic Network and Day services
Promote wider well being activity: Goal setting, problem solving, access to education and employment.Stress management – referral to Therapeutic Network and Day services
Draft 1 – july 2007. Written by Haringey PC LIT. Developed from Haringey and C&I guidelinesBack to contents
Primary Care Guidelines for Common Mental IllnessPrimary Care Guidelines for Common Mental Illness
Assessing & Managing Risk to Self– Suicide/Self-Harm
“Are you feeling like life is not worth living”or
“Have you had thoughts about harming or killing yourself?”
“Are you feeling like life is not worth living”or
“Have you had thoughts about harming or killing yourself?”
“Have you felt like acting on these thoughts”or
“Have you considered actually ending your life?
“Have you felt like acting on these thoughts”or
“Have you considered actually ending your life?
“Have you made any plans or preparations about how you would do this?”
Prompt: method, suicide note etc.
“Have you made any plans or preparations about how you would do this?”
Prompt: method, suicide note etc.
“How likely is it that you might act on these plans?”and
“Have you ever tried to harm yourself or end your life before?”Or (if psychotic)
“Have you heard voices telling you to harm yourself?”
“How likely is it that you might act on these plans?”and
“Have you ever tried to harm yourself or end your life before?”Or (if psychotic)
“Have you heard voices telling you to harm yourself?”
Yes
Likely/Yes
Yes
Yes
Unlikely/No
No
No
No
• Review routinely
• Enquire about risk again as appropriate
• Identify protective factors
• Review routinely
• Enquire about risk again as appropriate
• Identify protective factors
• Monitor regularly – every one to four weeks
• Check medication for toxicity & limit quantity
• Make shared action plan with patient about what they would do if felt more suicidal: eg. social support, contact GP, Samaritans, go to A&E etc.
• Active sharing of issues with carer
• Discuss with START if patient requires more intensive assessment
• Identify protective factors
• Monitor regularly – every one to four weeks
• Check medication for toxicity & limit quantity
• Make shared action plan with patient about what they would do if felt more suicidal: eg. social support, contact GP, Samaritans, go to A&E etc.
• Active sharing of issues with carer
• Discuss with START if patient requires more intensive assessment
• Identify protective factors
• Discuss directly with START or out of hours service 020 8442 6714
• If children in family – also consider referral to children services
• Discuss directly with START or out of hours service 020 8442 6714
• If children in family – also consider referral to children services
• The suicide rate in Haringey is 11.7/100 000 compared with the nation rate of 8.5/100 000 (based on 2006/7 GP registered population)
• Asking about suicide does not put the idea into someone’s head or increase the risk - patients are often relieved to have the chance to talk about their fears
• The suicide rate in Haringey is 11.7/100 000 compared with the nation rate of 8.5/100 000 (based on 2006/7 GP registered population)
• Asking about suicide does not put the idea into someone’s head or increase the risk - patients are often relieved to have the chance to talk about their fears
Suicide risk factors:
• History of prior attempts
• Current severity of depressive or other mental illness
• Alcohol & drug misuse
• Social isolation
• Low self esteem and perception of being a burden
• Rejected by loved ones
• Life-threatening/ chronic physical illness
• Being an single young man
• Impulsivity
• Recent discharge from psychiatric hospital
• Significant anniversaries
• Suicides in the family
Suicide risk factors:
• History of prior attempts
• Current severity of depressive or other mental illness
• Alcohol & drug misuse
• Social isolation
• Low self esteem and perception of being a burden
• Rejected by loved ones
• Life-threatening/ chronic physical illness
• Being an single young man
• Impulsivity
• Recent discharge from psychiatric hospital
• Significant anniversaries
• Suicides in the family
Consider risk of harm due to:
•Self-neglect
•Domestic violence
•Sexual vulnerability
• Child abuse
• Adult and elder abuse
•Risk from partner
Consider risk of harm due to:
•Self-neglect
•Domestic violence
•Sexual vulnerability
• Child abuse
• Adult and elder abuse
•Risk from partner
ASSESSMENTASSESSMENT MANAGEMENTMANAGEMENT
IdeationIdeation
RiskRisk
PlanningPlanning
IntentionIntention
Remember: Any previous suicide attempts are the biggest indicator of future risk
Thoughts of self-harm related to psychotic symptoms may increase risk.
Clin
ical
j ud g
e men
t – c
o nsi
der t
hat p
atie
nt m
ay b
e wit h
hold
i ng
i nfo
rmat
i on
Moderate RiskModerate Risk
Draft 1 – july 2007. Written by Haringey PC LIT. Developed from Haringey and C&I guidelines
Higher RiskHigher Risk
•Review routinely
•Enquire about risk again as appropriate
•Identify protective factors
Lower RiskLower Risk
Back to contents
Risk to children under 18years• Risk of harm to children direct or indirect?• See LSCB protocol• If in doubt, contact PCT child protection team
on 020 8442 6987
Risk to children under 18years• Risk of harm to children direct or indirect?• See LSCB protocol• If in doubt, contact PCT child protection team
on 020 8442 6987
Primary Care Guidelines for Common Mental IllnessPrimary Care Guidelines for Common Mental Illness
Assessing & Managing Risk - Harm to others
ASSESSMENTASSESSMENT MANAGEMENTMANAGEMENT
“Have you had thoughts about harming other people?” Hostile/ suspicious/ angry presentation. Evidence of paranoid/ persecutory delusions, command hallucinations. Worries that someone trying to hurt you? Felt need to protect self?
“Have you had thoughts about harming other people?” Hostile/ suspicious/ angry presentation. Evidence of paranoid/ persecutory delusions, command hallucinations. Worries that someone trying to hurt you? Felt need to protect self?
“Are you afraid you might act on these thoughts”Or Overt threats made to othersHave these been acted on?
“Are you afraid you might act on these thoughts”Or Overt threats made to othersHave these been acted on?
“Have you made any plans or preparations about harming someone?” (risk to partner/family?)
“How you would do this?” Prompt: method, access to means
“Have you made any plans or preparations about harming someone?” (risk to partner/family?)
“How you would do this?” Prompt: method, access to means
“How likely is it that you might act on these plans?”What has stopped these plans being carried out so far? Previous history of harm to others“Have you heard voices telling you to harm others?”
“How likely is it that you might act on these plans?”What has stopped these plans being carried out so far? Previous history of harm to others“Have you heard voices telling you to harm others?”
Yes
Likely/Yes
Yes
Yes
Unlikely/No
No
No
No
• Review
• Enquire about risk again as appropriate
•Identify protective factors
• Review
• Enquire about risk again as appropriate
•Identify protective factors
• Monitor regularly
• Make shared action plan with patient/ carers about what they would do if felt risk had increased: eg. social support, contact GP, go to A&E, contact police etc.
• Discuss with/ refer toSTART if patient requires more intensive risk monitoring or further assessment
• Monitor regularly
• Make shared action plan with patient/ carers about what they would do if felt risk had increased: eg. social support, contact GP, go to A&E, contact police etc.
• Discuss with/ refer toSTART if patient requires more intensive risk monitoring or further assessment
• Urgent telephone referral to START• If immediate risk call police on 999
• Urgent telephone referral to START• If immediate risk call police on 999
Higher RiskHigher Risk
Moderate RiskModerate Risk
Ideation/ Mental State
Ideation/ Mental State
RiskRisk
PlanningPlanning
IntentionIntention
Remember: Previous history of violent behaviour is the biggest indicator of future risk.
Violent thoughts related to acute psychotic symptoms may increase risk.
• There is no exact formula which can be used to assess the risk of harm to others – the following outlines some important factors to consider
• Clinical judgement is a key factor - concerns may sometimes be difficult to define . If unsure about what action to take, seek advice from ICS, your link worker or psychiatrist
• There is no exact formula which can be used to assess the risk of harm to others – the following outlines some important factors to consider
• Clinical judgement is a key factor - concerns may sometimes be difficult to define . If unsure about what action to take, seek advice from ICS, your link worker or psychiatrist
Harm to others - risk factors:
• Prior history of violent behaviour
• Diagnosis of schizophrenia, paranoid psychosis, personality disorder, severe depression
• Alcohol & drug misuse
• Unstable living arrangements
• Low educational attainment
• Unstable employment
• Being a younger man
• History of suffering chronic violence
Harm to others - risk factors:
• Prior history of violent behaviour
• Diagnosis of schizophrenia, paranoid psychosis, personality disorder, severe depression
• Alcohol & drug misuse
• Unstable living arrangements
• Low educational attainment
• Unstable employment
• Being a younger man
• History of suffering chronic violence
Clin
ical
jud g
e men
t – c
o nsi
der t
hat p
atie
nt m
ay b
e wit h
hold
i ng
i nfo
rmat
i on
Difficulty of assessing risk
Difficulty of assessing risk
Draft 1 – july 2007. Written by Haringey PC LIT. Developed from Haringey and C&I guidelines
•Review routinely
•Enquire about risk again as appropriate
•Identify protective factors
Lower RiskLower Risk
Back to contents
PROBLEM ISSUE
BOOK TITLE
AUTHOR(S) YEAR PROBLEM
ISSUE BOOK TITLE AUTHOR(S) YEAR
Anxiety
Overcoming Anxiety
Kennerley, Helen 1997 Social Anxiety/ Social Phobia
Overcoming Social Anxiety and Shyness
Butler, Gillian 1999
Overcoming Anxiety: A Five Areas Approach
Williams, Chris 2003 Stress
The Relaxation and Stress Reduction Workshop
Davis, Robbins, Eshelman & McKay
2000
Health Anxiety
Stop Worrying About Your Health!
Zgourides, George 2002
Managing Stress: Teach Yourself
Looker, Terry and Gregson, Olga
2003
Obsessions & Compulsions
Understanding Obsessions and Compulsions
Tallis, Frank 1992 Worry
How to Stop Worrying Tallis, Frank 1990
Panic
Overcoming Panic
Silove, Derrick 1997 Child Sexual Abuse (Adult Survivors)
The Courage to Heal Bass, Ellen and Davies, Laura
2002
Panic Attacks Ingham, Christine 2000 PTSD/Trauma
Overcoming Traumatic Stress
Herbert, Claudia & Wetmore, Ann
1999
Back to contents
PROBLEM ISSUE
BOOK TITLE
AUTHOR(S) YEAR PROBLEM
ISSUE BOOK TITLE AUTHOR(S) YEAR
Depression
Overcoming Depression
Gilbert, Paul 2000 Bereavement
Living with Loss McNeill Taylor, Liz 2000
Mind Over Mood
Greenberger, Dennis and Padesky, Christine
1995 Anorexia Nervosa
Breaking free from Anorexia Nervosa: A Survival Guide for Families, Friends and Sufferers
Treasure, Janet 1997
Overcoming Depression: A Five Areas Approach
Williams, Chris 2001
Overcoming Anorexia Nervosa
Freeman, Christopher & Cooper, Peter
2002
Self-Esteem
Overcoming Low Self-Esteem
Fennell, Melanie 1999 Binge-Eating Disorder and Bulimia Nervosa
Overcoming Binge Eating Fairburn, Chris 1995
Manic Depression
Overcoming Mood Swings
Scott, Jan 2001
Getting Better Bit(e) by Bit(e)
Schmidt, Ulrike and Treasure, Janet
1993
Back to contents
From 1stOctober 2007All referralsto Haringey Adult Mental Health Services should be made to:
START(Short term assessment and recovery team)
St Ann’s Hospital, St Ann’s Road, N15 3TH
020 8442 6714 or 6706
Fax 020 8442 6705START is the new single point of entry for mental health, replacing ERC and duty teams. The team is a MDT including psychiatry, nursing, social work and psychology.
START provides a 24 hour 7 day a week serviceBack to contents